Efficacy of Second-line Chemotherapy in Patients With Sensitive Relapsed Small-cell Lung Cancer

Background/Aim: To evaluate treatment efficacy of cisplatin, etoposide, and irinotecan combined therapy (PEI), platinum-rechallenge chemotherapy (Pt-Re) and amrubicin monotherapy (AMR) for patients with sensitive relapsed small cell lung cancer (SCLC). Patients and Methods: We defined sensitive rela...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:In Vivo
Autores principales: WAKUDA, KAZUSHIGE, MIYAWAKI, TAICHI, MIYAWAKI, ERIKO, MAMESAYA, NOBUAKI, KAWAMURA, TAKAHISA, KOBAYASHI, HARUKI, OMORI, SHOTA, NAKASHIMA, KAZUHISA, ONO, AKIRA, KENMOTSU, HIROTSUGU, NAITO, TATEAKI, MURAKAMI, HARUYASU, MORI, KEITA, ENDO, MASAHIRO, TAKAHASHI, TOSHIAKI
Formato: Artigo
Lenguaje:Inglês
Publicado: International Institute of Anticancer Research 2019
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899092/
https://ncbi.nlm.nih.gov/pubmed/31662561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11727
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares